Now onboarding clinics across Arizona and Texas.

A daily reading between appointments

GLP-1 patients are seen every few weeks. Rysflo measures the interval — a sixty-second breath reading each morning, on a shared dashboard, with nutrition guidance your staff review and send under the clinic’s name.

Request a demo Know more

HIPAA Compliant Patented technology

A roster view between visits

Every patient’s daily reading, flagged when one goes quiet.

~40%of GLP-1 patients stop within the first year

2 in 3of the weight lost returns after stopping

Lean massa substantial share of what is lost on-drug

Weeksbetween appointments, with no visibility in between

A handheld breath reader on both sides of the appointment

Each morning your patient sees three metabolic signals and the day’s targets. The same readings arrive in your dashboard.

For the patient

A reason to come back tomorrow

Proof in the first week

Fuel use shifts within days. A patient sees the programme working long before the next appointment, which is when most of them decide whether to keep going.

A plan that changes daily

That morning’s reading sets the day’s protein, carbohydrate, fat and fibre in grams — not a printout handed over at the last visit.

Habits that outlast the prescription

Daily streaks, completion rate, and a number that responds to what they did yesterday. The behaviour is what survives after the drug stops.

For the clinician

Visibility between visits

One roster, every patient

Level, last test and score at a glance. You can see who has gone quiet without opening a single profile.

Guidance your own team sends

Drafted nutrition, reviewed and approved by a nurse or in-house trainer, reaching the patient under your clinic’s name.

Fat loss, separated from lean loss

Acetone shows whether the weight is coming off stored fat. On a GLP-1 that is the question a scale cannot answer, and the one that decides whether a patient gets lighter or weaker.

What the prescription does not cover

Semaglutide and tirzepatide are the most effective weight-loss drugs available. The nutrition, adherence and monitoring around them are largely unmanaged.

TodayWith Rysflo

Visibility

None between visits

Between appointments the clinic has no data on the patient.

A live view of every patient

A daily breath reading and a shared dashboard show who is holding and who is slipping, in between.

Adherence

Not tracked

Nothing marks daily progress, so adherence decays without producing a signal.

A daily signal

Daily readings build a record of adherence. A reading that stops flags the patient ahead of the no-show.

Guidance

Not included

You prescribe the drug, but nothing guides what the patient eats or does around it.

Delivered by your staff

Personalised nutrition drafted from each patient’s own readings, reviewed and sent by your team under your name.

What the three signals show on-treatment

The drug’s effect on weight is well documented. The metabolic picture around it — through the transitions on and off, and in holding lean mass — is not routinely measured.

Fuel

Is the loss coming from fat?

A scale cannot separate fat from lean mass. Acetone shows whether the body is drawing on stored fat, so a falling weight can be read against evidence of fat oxidation rather than on its own.

Gut

Is the food being absorbed?

Slowed gastric emptying changes how food is handled. Hydrogen shows which meals are absorbed and which ferment — directly useful when appetite is suppressed and every meal has to count.

Fermentation

Is sugar being fermented?

Breath ethanol reports microbial fermentation of dietary sugar in the gut — an emerging signal, not a diagnosis.

How it sits in your clinic

No new hire, no new system to learn. Your existing staff deliver it, and it arrives under your clinic's name.

Devices The Rysflo device, ready to place with patients

You place devices

Patients test at home each morning, or in the clinic on a shared device at their visit.

Readings A patient taking a morning reading at home

Readings reach your dashboard

One roster view of every patient, with flags on anyone who has gone quiet or drifted.

Your team A drafted meal plan, ready for the clinical team to review

Your team reviews

Drafted nutrition guidance with the reasoning shown. A nurse or in-house trainer approves and sends it.

Patients

A patient and clinician looking at measured progress together

Progress stays visible

Measured progress between appointments supports adherence to the programme.

Up to 20%commission on every referral, each month it renews

No minimumno stock to buy and nothing to pay upfront

Freea device for your team to trial before you commit

What you see in the dashboard

Five views of every patient, from the same morning test.

Test Analysis in the Rysflo clinic dashboard

One score, three gases

A composite out of 100 with its zone, broken into acetone, hydrogen and ethanol in ppm. Every reading carries two explanations — a plain one, and the underlying science — so you can decide how deep to go.

What retention is worth to you

Set your own numbers. The model is yours, not ours.

A patient stays, on average 6 months Your programme price, per patient / month

Additional months you think a daily reading would add 3 months Patients on the programme

Added revenue per patient

$750

9 months retained instead of 6

Across your panel

$75,000

Request a demo

A model, not a projection. Rysflo has no published retention data, so the uplift above is the figure you set, not one we claim. Revenue is your programme fee and excludes the Rysflo subscription.

The weeks between appointments

A sixty-second reading each morning turns an unobserved interval into a record your team can act on.